Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Latham International is a UK-based engineering and manufacturing firm that provides specialized solid-liquid separation technology for the pharmaceutical, biotechnology, and healthcare sectors. The company is globally recognized for its "Latham centrifuge" and "Latham bowl" technology, which are critical components in extracorporeal photopheresis (ECP) systems used to treat immune-mediated conditions such as cutaneous T-cell lymphoma and graft-versus-host disease. In addition to medical centrifuges, Latham International manufactures high-precision filter presses used in the production of blood plasma products, agar-agar, and various pharmaceutical intermediates. The company serves a global client base from its headquarters in Newcastle-under-Lyme, offering new equipment, refurbishment services, and technical support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Latham International.